Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Lei-Yun Wang,1,2 Jia-Jia Cui,1,2 Ao-Xiang Guo,1,2 Ji-Ye Yin1,2 1Department of Clinical Pharmacology, XiangYa Hospital, Central South University, Changsha, 2Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, China Abstract: Compared wit...

Full description

Bibliographic Details
Main Authors: Wang LY, Cui JJ, Guo AX, Yin JY
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:OncoTargets and Therapy
Subjects:
Afatinib
NSCLC
Chinese patients
Drug resistance
Side effect
Companion diagnosis.
Online Access:https://www.dovepress.com/clinical-efficacy-and-safety-of-afatinib-in-the-treatment-of-non-small-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-efficacy-and-safety-of-afatinib-in-the-treatment-of-non-small-peer-reviewed-article-OTT

Similar Items